Papaveretum 20 mg and morphine 10-20 mg, with and without the addition of hyoscine, were compared as pre-operative medication, studying also the operative and postopsrative sequelae. It is shown that the morphine content of papaveretum 20 mg is equivalent to 13.3 mg of morphine sulphate and this dose was included in the comparison. Papaveretum caused a higher incidence of pre-operative drowsiness than the corresponding dose of morphine but the latter was more effective in relieving apprehension. There was no important difference in the toxic effects of the drugs during the first 90 minutes. There was less operative hypotension after papaveretum 20 mg than after any dose of morphine used but papaveretum-hyoscine had the highest incidence. Nausea and vomiting after papaveretum 20 mg were more frequent than after morphine 10 mg but similar in incidence to the sequelae of morphine 15 mg. In a small group of patients, papaverine in a dose many times greater than that found in papaveretum, behaves similarly to an inert substance with regard to both desired and toxic effects.
Papaveretum is described as "a preparation containing the water soluble alkaloids of opium, standardized to contain 50 per cent anhydrous morphine" (Wood-Smith and Stewart, 1964) . The suggestion that the opium alkaloids other than morphine might be beneficial as sedatives and analgesics was first made by Herman Sahli in 1907, and the preparation now known as papaveretum was introduced two years later by the firm of Roche under the name of Pantopon. It is also known as Omnopon, Opoidine, and Alopon.
In the half-century which has elapsed since its introduction conflicting assessments of its value in medicine have appeared. A number of workers claimed that papaveretum was superior to morphine either as premedication (Leipoldt, 1911; Axelrod, 1930; de Caux, 1932) in the relief of postoperative pain (Gray, 1911; Schall, 1917) or for both purposes (Price, 1947; Monat, 1946; Lattey, 1950) . These claims were all based on clinical impressions rather than on controlled studies. The specific aspects of drug action for which superiority over morphine was claimed include: greater sedation; easier induction of anaesthesia; more rapid recovery; fewer and less severe emetic effects; less depression of the circulatory, respiratory and renal systems; less constipating effects; greater analgesic potency; and a lower risk of habituation.
The degree of this enthusiasm can perhaps be judged by a quotation from a paper by Collins (1933) : "Pantopon can be recommended with the utmost confidence because there have been hundreds of clinical reports, both here and abroad attesting to the special advantages of Pantopon over morphine in producing a smoother anaesthesia." This statement of opinion coming as it did from Chicago, is particularly interesting, because only two years earlier, in 1931, the American Medical Association removed Pantopon from the list of New and Non-approved Remedies on the grounds that unjustified claims of superiority over morphine had been made in advertising. The basis for this official scepticism is not hard to find in the literature. Winternitz (1912) concluded that the residual alkaloids contributed little to the action of opium; Eggleston and Hatcher (1915) , using dogs, reported that papaveretum was slightly more emetic than could be accounted for by the morphine content alone. Barlow (1932) found no significant tranquilizing activity (in rats) on the part of the residual opium alkaloids and Hayman and Fox (1937) in a clinical trial were unable to demonstrate any activity of papaveretum in excess of that expected on the basis of its morphine content.
Two facts regarding the composition of papaveretum are worthy of note. The first is that its morphine content is greater than commonly supposed. The morphine alkaloid which constitutes 50 per cent of papaveretum is in the anhydrous form, while morphine sulphate (as used in clinical practice) contains 5 molecules of water of crystallization. If, therefore, 20 mg of papaveretum contains 10 mg of pure morphine alkaloid, the corresponding figures for 10 mg and 15 mg of morphine sulphate would be 7.6 mg and 11.4 mg respectively (table I) . Thus the true morphine content of papaveretum 20 mg is nearer to that of 15 mg rather than 10 mg of morphine sulphate, and for this reason papaveretum is compared with morphine 10 mg, 13.3 mg and 15 mg in this study. Morphine sulphate 13.3 mg contains the same amount of morphine alkaloid as papaveretum 20 mg.
The second point of interest is the very low content of codeine, narcotine and papaverine. Even when allowance is made for the fact that these constituents are expressed as pure alkaloid, while the corresponding therapeutic (analgesic) range given in table 1 refers to various salts, it is manifestly improbable that these substances could, in their own right, contribute significandy to the overall action of papaveretum. The question of possible drug synergism is discussed later.
Most current textbooks of pharmacology express the view that papaveretum should simply be regarded as equivalent to one-half of its own weight of morphine, and yet papaveretum, which is more expensive than morphine, continues to be very widely used in Great Britain.
This curious divergence between apparent logic and clinical experience prompted the authors to include papaveretum in investigations of various agents in pre-anaesthetic medication. The study was also undertaken because of the absence of objective information concerning the side effects of this preparation, most of the experimental data being concerned with the analgesic potency of papaveretum or its constituents.
For many years hyoscine has been associated with papaveretum, both in pre-anaesthetic medication and in the relief of pain; the trial was, therefore, extended to include a comparison of papaveretum 20 mg and hyoscine 0.4 mg. Since the 15-mg dose of morphine was not included in • "Therapeutic range" refers in the case of narcotine and papaverine to the dose of the corresponding salt which has been used experimentally, although neither has been found to be analgesic when given alone. this part of the study, the combinations will simply be referred to throughout the paper as papaveretum-hyoscine and morphine-hyoscine.
METHOD

Patients.
These were healthy women scheduled for minor gynaecological operations in one hospital unit. Details of numbers of patients, average ages, weights and durations of anaesthesia are shown in table II and indicate that the various groups are broadly comparable in all respects.
Premedication.
This consisted of papaveretum 20 mg, morphine 10 mg, 13.3 mg or 15 mg, papaveretumhyoscine, morphine-hyoscine or papaverine 32 mg, given by intramuscular injection. Atropine was not given to any patient.
To permit comparison of postoperative emetic sequelae, premedication was assigned in such a way that one half of the patients in each group required active dilatation of the cervix during the surgical procedure. Both patient and observer were ignorant of the nature of the drug administered in most instances, although in order to achieve the balance referred to, this safeguard had to be omitted in the final stages with each drug.
Pre-operative observations.
Detailed observations consisted of interviews at 20, 40, 60 and 90 minutes after administration of the drug. The desired and toxic effects were assessed according to the scheme described by Dundee, Moore and Nicholl (1962a) and Dundee, Moore and Clarke (1964) . Usually, detailed observations were made on one hah 0 of the subjects in each premedication group, but in the case of papaveretum additional "index only" cases were included so that the detailed series represented a smaller proportion of the whole. "Index only" observations were made during one interview 60-90 minutes after administration of the drugs, and were designed to elicit drug effects which had occurred throughout that period.
Anaesthesia.
Methohexitone 1.6 mg/kg was used for induction of anaesthesia which was maintained with 75 per cent nitrous oxide in oxygen, supplemental doses of methohexitone being injected as required. The course and complications of anaesthesia were assessed in the manner described by Dundee, Moore and Nicholl (1962b) .
Sequelae.
Patients were seen 1 hour and again 6 hours after the end of the operation, and the presence or absence of vomiting (including retching) and nausea were noted. The frequency and duration of these effects were graded according to the above scheme described by Dundee, Nicholl and Moore (1962) .
Number of cases.
In previous studies in this series, the number of observations was 100 with each drug, half of which had "detailed" pre-operation readings. In view of the composition of papaveretum already referred to, the results obtained in the first 100 cases were somewhat unexpected, and to eliminate possible error a further 50 cases were investigated fully and in an additional 100 cases the preoperative effect (index) only was studied. Thus the final pre-operative assessment was based on 250 cases, 150 of which were continued for detailed study of operation and postoperative sequelae.
In presenting results, direct comparisons of the effects of different doses of morphine have been avoided as far as possible, as this will be the subject of a further report.
RESULTS
Pre-operative observaticms.
The findings with the drugs given alone are shown in table ULA, while HIB summarizes the findings when hyoscine 0.4 mg was given in addition. Reference to table HIA shows a marked similarity between the results obtained in the two independent papaveretum series, and these were therefore pooled for further consideration.
Considering together patients having "good" and "fair" degrees of drowsiness, papaveretum 20 mg caused a higher incidence of marked preoperative drowsiness than morphine 10 mg (P<0.02) or morphine 15 mg (P<0.05). Papaveretum-hyoscine and morphine-hyoscine were followed by a greater hypnotic effect than either opiate given alone (P<0.005 and P<0.001 respectively) but did not differ significantly in this respect.
TABLE IIIA
Comparison of the pre-operative effects (percentage incidence) of papaveretum 20 mg, with morphine 10 mg, morphine 13.3 mg, morphine 15 mg, and papaverine 32 mg as observed 60-90 minutes after intramuscular injection. Apprehension was not relieved quite as effectively by papaveretum as by morphine 10 mg and morphine 15 mg and, although this property was augmented when they were combined with hyoscine, only in the case of morphine-hyoscine did this improvement attain 5 per cent confidence limits.
Drowsiness
Excitement, restlessness and pre-operative emetic effects were not prominent features of the action of any of these premedicants, and were noted with uniform frequency in the various series.
The addition .of hyoscine to morphine and papaveretum reduced the incidence of pre-operative emetic effects but in neither case to a significant extent. Dizziness occurred during the first 90 minutes after drug administration in between 30 and 45 per cent of patients, the incidence being unaffected when hyoscine was added to the opiate.
With most premedicants the heart rate rose to over 100 beats/min in about 25 per cent of cases. The incidence of tachycardia was notably reduced when hyoscine was combined with morphine as compared with morphine 10 mg given alone (P<0.0005) but no similar reduction was found with papaveretum-hyoscine.
Pre-operative hypotension was a rare finding in this investigation.
In table IV the pre-operative effects of the drugs are compared by means of their average efficacy, toxicity and net scores and it can be seen that, viewed in this overall manner, they are The detailed studies revealed no startling difference between the drugs and will not be reported in detail. With all preparations the maximum soporific and tranquillizing effects occurred about 1 hour after injection and were still unchanged at 90 minutes. The pattern of onset of side effects was similar for all drugs and their incidence and severity were still increasing 1£ hours after administration.
The series of cases premedicated with morphine 13.3 mg is of special interest as this dose contains the same amount of morphine alkaloid as papaveretum 20 mg without the other opium alkaloids. The pre-operative effects were similar to those with morphine 10 mg or 15 mg but were inferior to those of 20 mg papaveretum. As an example, drowsiness, was less marked with morphine alone (P<0.005).
Anaesthesia.
The course and complications of methohexitone nitrous oxide-oxygen anaesthesia following the most important premedicants are summarized in table V. Neither the total dosage of methohexitone required to maintain anaesthesia nor the incidence of excitatory phenomena following the induction was related significantly to the drug used before operation, although the latter complication occurred slightly more often when hyoscine was included.
Approximately 30 per cent of cases who were not given hyoscine showed respiratory upsets (cough, hiccough, laryngospasm), the incidence being significantly reduced when the antisialogogue was added (papaveretum P<0.025; morphine P<0.01). Clinically detectable respiratory depression was rare, and had no apparent relationship to the premedication used.
A fall in systolic blood pressure during anaesthesia of more than 20 mm Hg occurred in only 2 per cent of patients who had received papaveretum, which rendered it superior to the other "opiate alone" groups (e.g. compared with morphine 10 mg; P<0.005) papaveretum-hyoscine premedication was, on the other hand, followed by the highest incidence of hypotension found in this study.
When the quality of the anaesthesia obtained after different premedicants is compared by means of overall grading, certain differences emerge which reflect trends, although none reached accepted limits of significance. Papaveretum was better in this respect than morphine at any of the three dose levels, but in combination with hyoscine the position was reversed, morphine hyoscine being slightly superior to papaveretumhyoscine.
The deleterious effects of hyoscine on the course of anaesthesia were more marked with papaveretum (P<0.05) than with morphine and with this latter drug there was actually an increase in the incidence of trouble-free anaesthesia.
Recovery.
The condition of the patients 2 minutes after the end of anaesthesia was comparable in the groups given an opiate alone. The addition of hyoscine to papaveretum definitely prolonged recovery from anaesthesia. This did not apply to the morphine group in which the antisialogogue had a negligible effect on the number of patients "awake" at the time of observation but reduced the incidence of patients in whom the protective reflexes had not returned (unsafe) 2 minutes after the end of operation.
Sequelae.
During the first hour after operation the incidence of nausea and vomiting did not differ significantly between the "opiate only" premedication groups but was markedly reduced by the inclusion of hyoscine (papaveretum P<0.005, morphine P<0.0005). In the succeeding 5 hours (1-6 period) morphine 10 mg was associated with considerably fewer emetic symptoms than papaveretum 20 mg (P<0.025), but at the higher morphine dose (15 mg) the incidence was comparable.
Emetic sequelae after 13.3 mg morphine were intermediate in frequency and severity between the 10 and 15 mg dose of this drug and slightly less than that following 20 mg papaveretum. This latter difference is mainly due to a lower incidence of late nausea.
The incidence of postoperative nausea and vomiting following papaveretum-hyoscine and morphine-hyoscine were comparable over this period, but due to the lower emesis rate found after morphine alone as compared with papaveretum alone, the reduction attributable to the antiemetic activity of hyoscine only attained significant proportions in the case of papaveretum (P<0.001).
When the emetic symptoms occurring during the first 6 hours after operation were considered as a cumulative total, papaveretum was slightly less satisfactory than morphine 10 mg alone (P<0.1) but was comparable with morphine both in 13.3 mg and 15 mg dose. Hyoscine proved to be an effective anti-emetic, and considering the first 6 postoperative hours as a whole, the reduction in incidence of emetic sequelae reached significant levels with both papaveretum (P<0.005) and morphine (P<0.01).
Papaverine.
The effect of papaverine 32 mg was studied on only 20 patients, and although for purposes of comparison the results are expressed as percentages, they must be viewed with some caution. It is perhaps, sufficient to state that when papaverine 32 mg (some twenty times the amount in the standard ampoule of papaveretum) was giveu before operation the results differed in no significant manner from those obtained following the injection of an inert substance (unpublished data).
DISCUSSION
As stated previously, most of the claims for the superiority of papaveretum over morphine or other opiates are based on poorly controlled clinical investigations or in some cases on clinical impressions only. For this reason they will not be discussed in detail, but they are summarized and compared with the findings of the present study (table VH) . It is apparent that despite the low content of codeine, narcotine and papaverine these alkaloids must contribute in some way to the action of the preparation. Papaveretum 20 mg contains more morphine alkaloid than does morphine sulphate 10 mg and might therefore be expected to cause a higher incidence of marked drowsiness, but this does not explain its superiority in the same respect over morphine 13.3 mg and 15 mg or even over 20 mg (unpublished data), in which the alkaloid content is still greater. The remarkably low incidence of hypotension under anaesthesia, which was a consistent finding in a series of 150 patients to whom papaveretum was given, also seems to suggest a basic difference in the spectrum of pharmacological actions of papaveretum and morphine, while the fact that the addition of hyoscine to papaveretum markedly retards recovery from anaesthesia (whereas in the case of morphine it may actually accelerate it) is also difficult to explain purely on the basis of morphine content. Finally, the marked similarity between the results obtained using morphine 13.3 mg and morphine 10 mg and 15 mg underlines the effect of omitting the remaining alkaloids.
Observed under carefully controlled conditions, emetic complications do, however, appear to be closely related to the dose of morphine alkaloid administered and no evidence was found to suggest that the remaining opium alkaloids have significant anti-emetic properties.
The ability of papaveretum to relieve pain was not directly assessed. There was, however, no significant difference between papaveretum and morphine as regards the incidence of excitatory phenomena under methohexitone anaesthesia, which incidence was shown by Dundee (1965) to be correlated with the analgesic status of the premedicants used, and the total methohexitone dosages were very similar. Unpublished work carried out in this department on postoperative pain suggests that the analgesic potency of papaveretum 20 mg lies between morphine 10 mg and 15 mg, and this is in agreement with the findings of Hayman and Fox (1937) .
Since the method of assessment of respiratory depression in this study is, at best, rather insensitive the results do not necessarily refute the possibility that morphine-induced respiratory depression may be antagonized by the other alkaloids contained in papaveretum.
In view of the popularity of "Omnopon and Scopolamine" premedication some important effects of papaveretum and morphine are compared with those wh;n each opiate is combined with hyoscine (table VIII) . It is interesting to note that whereas morphine-hyoscine is superior to morphine alone on three counts out of five, and is equally desirable on the remaining two, papaveretum-hyoscine is superior to papaveretum alone only in the production of drowsiness, and is significantly less desirable from two other aspects. There would appear to be little indication for combining hyoscine with papaveretum in preference to morphine in pre-operative medication.
The general subject of drug synergism and antagonism is beyond the scope of this paper, but there is some evidence to suggest that the combination of some of the opium alkaloids in papaveretum can be beneficial. Macht, Herman and Levy (1916) found in human subjects that morphine plus narcotine raised the pain threshold to a greater extent than did larger doses of either alone. Macris and co-workers (1958) found that the analgesic effectiveness of a standard dose of morphine, when given to patients suffering from postoperative pain was increased when it followed the administration of papaverine. JeurgensonStender (1936) noted that a mixture of codeine phosphate, narcotine, papaverine and thebaine prolonged the local anaesthetic action of cocaine in the eye almost to the same extent as did morphine, and Torkell and Woods (1965) found that the addition of a very small amount of either codeine or morphine to a larger dose of the other alkaloid considerably prolonged its analgesic action in the rat.
The fact that the analgesic efficacy of morphine is enhanced by the addition of various single alkaloids, while the mixture found in papaveretum does not appear to have this effect, would suggest that, from the aspect of analgesic potency at least, this combination is not optimal.
In conclusion it can be stated that while papaveretum is not greatly superior to morphine in any way, at least the actions of the two drugs differ in some respects. The properties of papaveretum are not entirely dependent on its morphine content and, with a view to both the augmentation of the desirable and elimination of the less desirable aspects of opiate action, re-examination of various permutations of the opium alkaloids might be rewarding.
ADDENDUM
This study is based on the current (April 1966) content of papaveretum ampoules, namely 20 mg. Some older supplies may be labelled j-grain, i.e. 21.6 mg.
ETUDE DES DROGUES DONNEES AVANT L'ANESTHESIE XII: COMPARAISON DU PAPAVERETUM ET DE LA MORPHINE
SOMMAIEE
On a compart comme medication pr6-operatoire 20 mg de papaveretum et 10-20 mg de morphine, avec ct sans addition d'hyoscine, en etudiant aussi les sequelles operatoires et post-operatoires. On montre que la teneur en morphine de 20 mg de papaveretum est de 133 mg et cette dose de morphine a iti induse dans la comparaison. Le papaveretum a caus6 une plus forte incidence de somnolence pr£-operatoire que la dose correspondante de morphine, mais cette derniere a iti plus efficace pour attenuer l'apprenension. II n'y a pas eu de difference importante dans les effets toxiques des drogues au cours des 90 premieres minutes. II y a eu moins d'hypotension opiratoire apres 20 mg de papaveretum qu'apres l'une ou l'autre dose de morphine, mais le papaveretum-hyoscine a eu la plus forte incidence. Nausfes et vomissements apres 20 mg de papaveretum 6taient plus frequents qu'apres 10 mg de morphine. Dans un petit groupe de malades, la papavinne a une dose de beaucoup supeneure a celle que l'on trouve dans le papaveretum s'est conduite comme une substance inerte tant pour les effets recherches que pour les effets toxiques. On discute d'une facon g&ieralc la question de la potentialisation de la morphine par Tun ou l'autre des alcaloides contenus dans le papaveretum. 
